A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: Results of the phase II randomized ABIGAIL study (BO21015)

Mok T.Gorbunova V.Juhasz E.Szima B.Burdaeva O.Orlov S.CHONG-JEN YUArcher V.Hilton M.Delmar P.Pallaud C.Reck M.2022-06-272022-06-2720141556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901595989&doi=10.1097%2fJTO.0000000000000160&partnerID=40&md5=b47ad2f942c27e7a13eb86692d3d9dbehttps://scholars.lib.ntu.edu.tw/handle/123456789/614213A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: Results of the phase II randomized ABIGAIL study (BO21015)journal article10.1097/JTO.0000000000000160248071562-s2.0-84901595989